Outcome Following Acute Myocardial Infarction

Open Access

12 July 1999

journal article
research article
Published by American Medical Association (AMA) in Archives of internal medicine (1960)

Vol. 159 (13) , 1429-1436
https://doi.org/10.1001/archinte.159.13.1429

Abstract

DURING THE past 3 decades, there has been a 47% decline in age-adjusted mortality for acute myocardial infarction (MI) in the United States.¹ Clinical trials have shown that mortality from acute MI can be significantly reduced by the use of primary angioplasty,²^-7 thrombolytic therapy,⁸^,9 aspirin,⁹^,10 β-adrenergic blocking agents,¹¹^,12 angiotensin-converting enzyme (ACE) inhibitors,¹³^,14 and perhaps by avoiding the use of calcium channel blockers.¹⁵^-18

This publication has 1 reference indexed in Scilit:

Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients
Published by Elsevier ,1994